Ignite Creation Date:
2024-05-06 @ 12:19 AM
Last Modification Date:
2024-10-26 @ 10:48 AM
Study NCT ID:
NCT01544920
Status:
COMPLETED
Last Update Posted:
2018-09-11
First Post:
2012-02-28
Brief Title:
Safety and Efficacy of BoceprevirPeginterferon Alfa-2aRibavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus HCV Genotype 1 Participants P07755
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05-30
Start Date Type:
ACTUAL
Primary Completion Date:
2015-05-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-05-19
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-28
First Submit QC Date:
March 5 2012
Study First Post Date:
2012-03-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-05-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-13
Last Update Post Date:
2018-09-11
Last Update Post Date Type:
ACTUAL